Search research articles
Contact Us
Filters
Showing results (241-250 of 314) with videos related to
Page
of 32
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 5, 2010
Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma
Roger Stupp, Monika E Hegi, Bart Neyns, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 8, 2023
ERK1/2 Phosphorylation Predicts Survival in Recurrent Glioblastoma Following Intracerebral and Adjuvant PD-1/CTLA-4 Immunotherapy: A REMARK-guided Analysis
Víctor A Arrieta, Johnny Duerinck, Kirsten B Burdett, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 30, 2018
Multimodal Treatment in Operable Stage III NSCLC: A Pooled Analysis on Long-Term Results of Three SAKK trials (SAKK 16/96, 16/00, and 16/01)
Martin Früh, Daniel C Betticher, Roger Stupp, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 13, 2022
Translocon-associated Protein Subunit SSR3 Determines and Predicts Susceptibility to Paclitaxel in Breast Cancer and Glioblastoma
Crismita Dmello, Aarón Sonabend, Victor A Arrieta, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 20, 2025
Pharmacokinetic analysis of carboplatin and fluorescein brain permanence following ultrasound-based blood-brain barrier opening
Karl J Habashy, Timothy W Synold, Ye Feng, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 17, 2019
The added value of health-related quality of life as a prognostic indicator of overall survival and progression-free survival in glioma patients: a meta-analysis based on individual patient data from randomised controlled trials
Marijke Coomans, Linda Dirven, Neil K Aaronson, et al.
Journal of Neurosurgery
|
October 29, 2013
The accuracy of predicting survival in individual patients with cancer
Douglas Kondziolka, Phillip V Parry, L Dade Lunsford, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 4, 2018
IDO1 Inhibition Synergizes with Radiation and PD-1 Blockade to Durably Increase Survival Against Advanced Glioblastoma
Erik Ladomersky, Lijie Zhai, Alicia Lenzen, et al.
Neuro-Oncology
|
April 11, 2022
Factors associated with health-related quality of life (HRQoL) deterioration in glioma patients during the progression-free survival period
Marijke B Coomans, Linda Dirven, Neil Aaronson, et al.
The New England Journal of Medicine
|
March 11, 2005
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
Roger Stupp, Warren P Mason, Martin J van den Bent, et al.
Page
of 32
Search research articles
Search
Showing results (241-250 of 314) with videos related to
Sort By:
Page
of 32
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 5, 2010
Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma
Roger Stupp, Monika E Hegi, Bart Neyns, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 8, 2023
ERK1/2 Phosphorylation Predicts Survival in Recurrent Glioblastoma Following Intracerebral and Adjuvant PD-1/CTLA-4 Immunotherapy: A REMARK-guided Analysis
Víctor A Arrieta, Johnny Duerinck, Kirsten B Burdett, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 30, 2018
Multimodal Treatment in Operable Stage III NSCLC: A Pooled Analysis on Long-Term Results of Three SAKK trials (SAKK 16/96, 16/00, and 16/01)
Martin Früh, Daniel C Betticher, Roger Stupp, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 13, 2022
Translocon-associated Protein Subunit SSR3 Determines and Predicts Susceptibility to Paclitaxel in Breast Cancer and Glioblastoma
Crismita Dmello, Aarón Sonabend, Victor A Arrieta, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 20, 2025
Pharmacokinetic analysis of carboplatin and fluorescein brain permanence following ultrasound-based blood-brain barrier opening
Karl J Habashy, Timothy W Synold, Ye Feng, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 17, 2019
The added value of health-related quality of life as a prognostic indicator of overall survival and progression-free survival in glioma patients: a meta-analysis based on individual patient data from randomised controlled trials
Marijke Coomans, Linda Dirven, Neil K Aaronson, et al.
Journal of Neurosurgery
|
October 29, 2013
The accuracy of predicting survival in individual patients with cancer
Douglas Kondziolka, Phillip V Parry, L Dade Lunsford, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 4, 2018
IDO1 Inhibition Synergizes with Radiation and PD-1 Blockade to Durably Increase Survival Against Advanced Glioblastoma
Erik Ladomersky, Lijie Zhai, Alicia Lenzen, et al.
Neuro-Oncology
|
April 11, 2022
Factors associated with health-related quality of life (HRQoL) deterioration in glioma patients during the progression-free survival period
Marijke B Coomans, Linda Dirven, Neil Aaronson, et al.
The New England Journal of Medicine
|
March 11, 2005
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
Roger Stupp, Warren P Mason, Martin J van den Bent, et al.
Page
of 32